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4] has been established, factors negatively 
influencing variability in calcium-scoring 
CT, such as image noise [5], intraobserver 
and interobserver variability [6], motion ar-
tifacts [7], and partial volume effects [8], 
have always been deemed to have too great 
an influence on ungated low-dose MDCT to 
consider it a reasonable alternative. However, 
two studies [9, 10] comparing calcium mea-
surements in low-dose ungated MDCT with 
results from ECG-gated MDCT concluded 
that comparable results can be obtained.
To be truly useful as a screening tool for 
cardiovascular disease, low-dose ungated 
MDCT should also show sufficient interscan 
agreement. Even in MDCT performed spe-
cifically for calcium scoring, substantial vari-
ability occurs in repeated scans of the same 
person [11]. However, if calcium scoring in 
low-dose ungated MDCT is used as a marker 
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B
ecause prolonged and heavy 
smoking is a strong etiologic fac-
tor in the development of lung 
cancer and cardiovascular dis-
ease (CVD), simultaneous screening for both 
diseases in a high-risk population of heavy 
smokers and former smokers is an attractive 
strategy for maximizing the beneficial ef-
fects on survival in lung cancer screening 
programs and minimizing the radiation dose 
for individuals in the screening population. 
The presence and extent of coronary artery 
calcification (CAC) detected with electron-
beam CT and ECG-gated MDCT have been 
found to be independent predictors of CVD 
events [1]. By contrast, screening for lung 
cancer is performed with low-dose ungated 
MDCT scanning protocols. Although the 
clinical importance of CAC detected with 
both ungated MDCT [2] and low-dose CT [3, 
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OBJECTIVE. In previous studies detection of coronary artery calcification (CAC) with 
low-dose ungated MDCT performed for lung cancer screening has been compared with de-
tection with cardiac CT. We evaluated the interscan agreement of CAC scores from two con-
secutive low-dose ungated MDCT examinations.
SUBJECTS AND METHODS. The subjects were 584 participants in the screening 
segment of a lung cancer screening trial who underwent two low-dose ungated MDCT ex-
aminations within 4 months (mean, 3.1 ± 0.6 months) of a baseline CT examination. Agat-
ston score, volume score, and calcium mass score were measured by two observers. Interscan 
agreement of stratification of participants into four Agatston score risk categories (0, 1–100, 
101–400, > 400) was assessed with kappa values. Interscan variability and 95% repeatabil-
ity limits were calculated for all three calcium measures and compared by repeated measures 
analysis of variance.
RESULTS. An Agatston score > 0 was detected in 443 baseline CT examinations (75.8%). 
Interscan agreement of the four risk categories was good (κ = 0.67). The Agatston scores were 
in the same risk category in both examinations in 440 cases (75.3%); 578 participants (99.0%) 
had scores differing a maximum of one category. Furthermore, mean interscan variability 
ranged from 61% for calcium volume score to 71% for Agatston score (p < 0.01). A limitation 
of this study was that no comparison of CAC scores between low-dose ungated CT and the 
reference standard ECG-gated CT was performed.
CONCLUSION. Cardiovascular disease risk stratification with low-dose ungated 
MDCT is feasible and has good interscan agreement of stratification of participants into Ag-
atston score risk categories. High mean interscan variability precludes the use of this tech-
nique for monitoring CAC scores for individual patients.
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for predicting CVD events, the main concern 
should be not the absolute or relative inter-
scan variability of calcium scores but correct 
stratification of patients into CVD risk cat-
egories, such as the system based on the Ag-
atston score described by Rumberger et al. 
[12]. Those authors suggested clinically ap-
plicable cutoffs in the continuous Agatston 
score (0, low risk; 1–100, mild risk; 100–
400, moderate risk; and > 400, high risk) that 
correspond to increasing levels of risk of cor-
onary events. In analogy to application of the 
Framingham risk score, patients in the high-
est risk category (> 400) need aggressive 
preventive treatment of CVD risk factors, 
and this recommendation should possibly 
be extended to patients in the intermediate 
risk category (100–400). The main purpose 
of our study was to determine the interscan 
agreement of Agatston score risk categories 
in repeated low-dose ungated MDCT in an 
evaluation of the usefulness of this technique 
for prediction of CVD events in participants 
in a lung cancer screening trial.
Subjects and Methods
Approval was obtained from the institutional re-
view committees of all participating study sites. In-
formed consent was obtained from all participants.
Participants
A search of population registries yielded 
the cases of 15,822 subjects between 50 and 75 
years of age who were recruited to participate 
in the Nederlands-Leuvens Longkanker Screen-
ings Onderzoek (NELSON) study, a lung cancer 
screening trial performed in four regions in The 
Netherlands and Belgium. The inclusion criteria 
were, first, that participant was a current or former 
smoker with a smoking history of more than 15 
cigarettes per day for more than 25 years or more 
than 10 cigarettes per day for more than 30 years 
who stopped smoking more than 10 years before 
study enrollment and, second, that the participant 
be able to climb two or more flights of stairs. A de-
tailed description of patient selection for the study 
has been published [13].
Between April 2004 and July 2006, 7,557 par-
ticipants randomized to the screening group at 
four participating medical centers underwent a 
baseline CT examination. For the current study, a 
subgroup of 584 participants (497 men, 87 wom-
en; mean age, 59.9 ± 5.8 [SD] years) from one of 
the four participating centers was identified who 
underwent repeated scanning within 4 months 
of the baseline CT scan. The indication for rep-
etition of CT was detection of a pulmonary nod-
ule measuring 50–500 mm3 at baseline CT [14]. 
The mean period between the baseline and re-
peated scans was 3.1 ± 0.6 months (range, 2.0–4.0 
months). That only limited progression of CAC 
can be expected in this short interval [15] made 
this opportunity a good one for investigating the 
interscan variability of CAC measurements.
Low-Dose Chest CT Protocol
All baseline and repeated CT scans performed 
at the participating study site were conducted 
with a 16-MDCT scanner (Mx8000 IDT, Philips 
Healthcare). Scanning was performed in helical 
mode with 16 × 0.75 mm collimation and pitch of 
1.3–1.5. The scanning parameters have been de-
scribed extensively [14]. Transverse images with 
1.0-mm section thickness and a 0.7-mm increment 
were acquired from the level of the lung bases to 
the lung apices. The smallest field of view was 
chosen to include the outer rib margins at the wid-
est dimension of the chest.
Acquisition was performed at suspended maxi-
mal inspiration after the participant received in-
structions about breath-holding. Total acquisition 
duration was a single breath-hold (≈ 10 seconds). 
No ECG triggering was performed; no contrast 
agent was administered. For the analysis of CAC, 
the raw data were reconstructed into 3.1-mm over-
lapping sections with a 1.4-mm increment. Low-
dose exposure settings were applied according to 
body weight: 30 mAs at a tube voltage of 120 kVp 
for participants weighing 80 kg or less and 30 mAs 
at a tube voltage of 140 kVp for subjects weighing 
more than 80 kg. Radiation exposure (volume CT 
dose index) was 2.2 mGy for the lighter and 3.5 
mGy for the heavier participants.
CAC Assessment
All CAC scoring was performed with software 
described by Isgum et al. [16]. Two readers, a re-
search physician with 2 years of experience and a 
radiologist with 3 years of experience in cardiac 
CT, blinded to the participant’s age, sex, and name, 
independently read the images from all 1,168 CT 
scans. Images from the two scans of a single par-
ticipant were read by one observer at least 2 weeks 
apart to eliminate the effect of interobserver vari-
ability. Scan pairs were divided equally between the 
two readers. Before the study, both readers reviewed 
a training set of images from 50 randomly selected 
CT scans in the NELSON study database to assess 
interobserver variability (intraclass R = 0.97).
Calcium scoring software written in C++ was 
used to define calcified plaque as all regions of 
three or more adjoining voxels (0.7 mm3) with at-
tenuation greater than 130 HU. An investigator 
manually identified a point in each calcified le-
sion. Three-dimensional component labeling with 
26-connectivity was automatically performed to 
mark all connected voxels as calcification. Care 
was taken not to include noncoronary calcifica-
tions (e.g., valve calcifications) and hyperattenu-
ating foci due to image noise [16, 17]. Total Ag-
atston score, calcium volume score, and calcium 
hydroxyapatite mass score were output by the soft-
ware program as outlined by Ulzheimer and Kal-
ender [18]. Separate scores were calculated for the 
left main, left anterior descending, left circumflex, 
and right coronary arteries. Agatston scores were 
further categorized into four groups (0, 1–100, 
101–400, and > 400) to be used for CVD risk 
stratification as outlined by Rumberger et al. [12].
Statistical Analysis
Intraclass correlation coefficients, kappa val-
ues, and variability were used to express interob-
server and interscan agreement of CAC scores. 
First, the presence of CAC (Agatston score > 0) on 
scan 1 versus the presence of calcification on scan 
2 was assessed for all participants (n = 584). Dis-
agreement between the presence of CAC on two 
scans of the same patient was counted as a discor-
dant pair. Agreement on the presence (yes or no) 
of calcium was calculated with kappa statistics.
All participants were additionally stratified into 
a CVD risk category for scan 1 and for scan 2 on the 
basis of Agatston score: 0, low risk; 1–100, moder-
ate risk; 101–400, intermediate risk; and > 400, 
high risk [12]. Agreement of risk category stratifi-
cation also was assessed with kappa statistics. Rel-
ative interscan variability of two CAC scores was 
calculated as: absolute (score 1 – score 2) / mean 
(score 1 + score 2) × 100%. In participants with an 
Agatston score > 0 in at least one scan (n = 461), we 
used the regression method for nonuniform differ-
ences to establish 95% repeatability limits for all 
three measures [19]. In this method, the absolute 
interscan difference (D) of each calcium measure 
was linearly modeled against the mean calcium 
measures (M). All models were adjusted for the 
total amount of calcium, measured according to 
the mean (natural log transformed) calcium score. 
We chose to force these models through the origin 
because the interscan difference is zero when the 
mean calcium measure is zero [20]. The resulting 
regression line is D = b1M, where b1 is the slope 
of the line.
We then modeled the absolute values of the un-
standardized residuals (|R|) from the previous re-
gression models against the mean calcium mea-
sures (M): R = c0 + c1M, where c0 is the intercept 
and c1 is the slope of the regression line. The 95% 
repeatability interval can be calculated by com-
bining the two regression equations as follows: 
b1M ± 2.46(c0 + c1M). On the assumption that 
the systematic difference between the two scans 
(b1M) equals zero, this equation can be written as 
1246 AJR:194, May 2010
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2.46(c0 + c1M). In this method, 2.46 is substitut-
ed for 1.96 because it is assumed that the absolute 
values of the residuals follow a half-normal distri-
bution. It therefore is necessary to multiply 1.96 by 
√π / 2 [19]. Absolute interscan difference was plot-
ted against mean calcium score with the Bland-Alt-
man approach. The equation 2.46(c0 + c1M) can be 
used to calculate the upper and lower 95% repeat-
ability limits for the absolute interscan difference 
of a mean calcium score value. Repeated measures 
analysis of variance was used to assess differences 
in relative interscan differences in the three calci-
um measures. Wilcoxon’s tests were used for post 
hoc comparisons and p for significance modified 
by Bonferroni adjustment (p < 0.018).
Results
A total of 584 participants (497 men, 87 
women; mean age, 59.9 ± 5.8 years) were in-
cluded in this study. Figure 1 shows the fre-
quency distribution of CAC on the baseline 
scans of all 584 participants subdivided into 
Agatston score–based risk categories. A to-
tal of 443 participants (75.8%) had any CAC 
(Agatston score > 0) detected on the baseline 
CT scan. The median Agatston score at base-
line was 80.3 (range, 0–9,596) and at repeat-
ed CT was 78.1 (range, 0–7,659). Agreement 
between absolute Agatston scores on two 
low-dose ungated CT scans was an intraclass 
correlation coefficient of 0.94.
Overall agreement between scans for the 
presence (yes or no) of any CAC was 91.6% 
(535 of 584 participants). Only 49 pairs of 
scans (8.4%) were discordant, resulting in a 
good kappa value of 0.78. Figure 2 is a bar 
chart of the distribution of absolute Agatston 
scores of the 49 participants with CAC in 
only one scan (discordant pairs). Thirty-five 
of these participants (71.4%) had an Agatston 
score < 10, which was negligible and was like-
ly caused by minor motion artifacts. Only two 
participants (4.1%) had Agatston scores that 
were substantially out of range (maximum, 
278.7) owing to major motion artifacts.
Table 1 shows the interscan agreement of 
Agatston scores on two low-dose CT scans 
of the same patient for the four categories 
used in CVD risk stratification. In approxi-
mately three of four participants (440 of 584, 
75.3%), no shift in Agatston score risk cat-
egory occurred between scan 1 and scan 2. 
The unweighted kappa statistic showed good 
agreement (κ = 0.67) [21]. A shift of more 
than one category was found in only eight of 
the participants (1.4%).
Figure 3 shows standard Bland-Altman 
plots in which the means of calcium scores 
from scan 1 and scan 2 are plotted against 
the adjusted absolute interscan difference. As 
expected, all three plots show a nonuniform 
relation between the extent of CAC and the 
measurement error; that is, interscan variabil-
ity increased as the total amount of calcium 
increased. Standard 95% CIs (calculated as 
the mean difference ± 1.96 × SD) do not cor-
respond well with this type of relation. There-
fore, 95% confidence limits were calculated 
with nonuniform regression analysis and are 
represented by lines on the plots. The slopes 
of these lines (r) can be interpreted as a mea-
sure of reproducibility. The steeper the slope 
of this line (higher value of r), the less repro-
ducible is the calcium measure. The vertical 
distance between the lines indicates the mea-
surement error (95% CI) for a given mean cal-
cium score value; that is, 95% of the time the 
absolute interscan difference for a given cal-
cium score will fall within these limits. In this 
study, calcium volume score (r = 0.5175) had 
better reproducibility than Agatston score (r = 
0.5985) and calcium mass score (r = 0.5696). 
Table 2 shows the relative interscan variabil-
ity for all three calcium measures in partici-
pants who had any CAC on at least one of two 
CT scans (n = 461). A statistically significant 
difference (p < 0.01) was found in pairwise 
comparison of the means of variability of the 
three calcium measures.
Discussion
We found that use of a low-dose ungated 
MDCT technique for detection and quantifi-
cation of CAC in a lung cancer screening trial 
gives good interscan agreement in the assign-
ment of participants to Agatston score catego-
ries for CVD risk stratification. These results 
support the idea that CAC scoring as part of 
low-dose ungated MDCT can be a useful tool 
for assessing the risk of CVD among persons 
undergoing lung cancer screening.
Our results provide incremental evidence 
to the conclusions of two previous studies 
[9, 10] of this issue. Both studies compared 
a low-dose ungated MDCT protocol and an 
ECG-gated CT protocol (the reference stan-
dard for CAC scoring) with respect to accu-
racy in detection and categorization of CAC. 
Using a 40-MDCT unit, Kim et al. [9] found 
concordance of 83% (n = 106) in stratifying 
participants into the same risk category with 
low-dose CT compared with ECG-gated CT 
and a maximum difference of only one cat-
egory in the other 12 participants. Wu et al. 
TABLE 1: Risk Stratification of Subjects by Agatston Score Risk Category 
From Baseline and Repeated Low-Dose Ungated MDCT
Baseline 
Score
Score at Repeated MDCT
Total0 1–100 101–400 > 400
0 125 18 0 0 143
1–100 29 102 26 2 159
101–400 2 22 59 27 110
> 400 0 4 14 154 172
Total 156 146 99 183 584
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Fig. 1—Frequency histogram shows distribution 
of Agatston scores from baseline CT scans of 584 
subjects.
Fig. 2—Bar chart shows distribution of Agatston 
scores among 49 participants with coronary artery 
calcium in only one of two scans (discordant pairs).
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[10], using a 16-MDCT unit, found concor-
dance of 93% (n = 450) compared with the 
reference standard.
Apart from good agreement with ECG-
gated MDCT, it is important to find reliably 
good agreement between CAC scores on re-
peated CT scans of the same patient. Al-
though mean variability between scores on 
both CT examinations was as high as 60–
70%, we found that 75% of participants were 
placed in the same risk category on two low-
dose ungated MDCT scans (κ = 0.67). Taken 
together, these results support the idea that 
CAC scoring of absolute calcium scores in 
low-dose ungated MDCT may not be highly 
accurate but can be used reliably for CVD 
risk stratification.
An important difference between the two 
previous studies and ours is the racial make-
up of the study populations. The two previ-
ous studies [9, 10] were conducted with self-
referred Asian populations, resulting in a 
low prevalence of CAC compared with our 
study, which was conducted with a predomi-
nantly white population. Because variability 
in scores (whether between or within tech-
niques) is strongly related to the total amount 
of calcification that can be scored in an indi-
vidual, it is an important strength of this study 
that comparable results were found in a popu-
lation with a far higher prevalence of CAC.
In an earlier study, Shemesh et al. [22] 
used visual (semiquantitative, grade 0–12) 
grading of CAC to determine CAC scores in 
4,250 participants in a lung cancer screen-
ing study. They concluded that with this tool, 
CAC scoring can be used for CVD risk strati-
fication. Their choice to perform visual grad-
ing might have stemmed from the fact that 
their study was performed with a 4-MDCT 
unit, resulting in less spatial and temporal 
resolution than can be achieved with a 16-
MDCT unit. Semiautomated scoring has the 
advantage over visual grading with respect to 
interobserver and intraobserver reproducibil-
ity. The subjective assessment (size, attenua-
tion) of a vascular calcification is replaced by 
a software tool, with which calcifications are 
identified on the basis of a clear attenuation 
threshold (130 HU) and calcium scores are 
automatically calculated.
Apart from interscan agreement of Agat-
ston risk categories, we investigated the util-
ity of low-dose ungated MDCT in detection 
of the presence (yes or no) of CAC between 
two examinations. A previous report [23] 
showed that the absence of any CAC, though 
not completely excluding the risk of coro-
nary artery disease, is an important indica-
tor of absence of significant (> 50%) steno-
sis of the coronary arteries. Therefore, a high 
negative predictive value for interscan com-
parisons is desirable. The rate of occurrence 
of discordant pairs (calcium disappearing or 
suddenly appearing between two examina-
tions) in our study was 8%. The rates of re-
porting of discordant pairs in previous stud-
ies of interscan agreement performed with 
ECG gating or triggering and varied tube 
currents have ranged from 0% to 6% [3, 17, 
24, 25]. The result in our study is only mod-
erately worse than these rates of discordant 
pairs and was obtained at a considerably re-
duced radiation dose to each participant. In 
most cases, the higher noise levels in low-
dose ungated MDCT than in ECG-gated 
MDCT are the cause of discordance [5]. Use 
of a body weight–adapted scanning protocol 
for low-dose ungated MDCT may improve 
noise levels [26]. Even at present, however, 
the absence or presence of CAC can be estab-
lished reliably in 92% of subjects.
With respect to interscan variability, recent 
studies [3, 25, 27] conducted with ECG-gated 
MDCT have shown interscan variability rang-
ing from 12% to 32%, and studies [5, 8, 28–
32] of electron-beam CT conducted in the late 
1990s showed variability ranging from 13% 
to 51% for both Agatston and calcium volume 
score algorithms. We have found interscan 
variability of 60–70%. Therefore, we have to 
conclude that ECG-gated techniques remain 
the reference standard for obtaining accurate 
CAC scores in individual patients and mon-
itoring of CAC over time, but low-dose un-
gated CT can be used for adequate CVD risk 
stratification in screening populations.
Although percentage differences are the 
most common way to present variability, we 
emphasize that this measure is inappropriate 
for inferring true variability. Only absolute 
differences in scores reflect the true variability 
(e.g., an absolute interscan difference of only 8 
TABLE 2: Interscan Variability of Coronary Artery Calcification in Participants 
With Agatston Score > 0 on At Least One Scan (n = 461)
Value Agatston Score Volume Score Mass Score
Intraclass correlation coefficient 0.94 0.95 0.94
Mean variability (%) 71 61 65
Median variability (%) 51 36 43
Note—Post hoc comparisons after a repeated measures analysis of variance showed statistically significant 
(p < 0.01) differences in mean variability of all three calcium measures.
3,000
1,000
R
es
ca
n 
D
iff
er
en
ce
 in
A
ga
ts
to
n 
Sc
or
e
0
−1,000
−2,000
−3,000
0 2,000 4,000 6,000 8,000 10,000
Mean Agatston Score
2,000
2,000
R
es
ca
n 
D
iff
er
en
ce
 in
Vo
lu
m
e 
Sc
or
e
0
−2,000
0 1,000 2,000 3,000 4,000 5,000 7,0006,000
Mean Volume Score
400
R
es
ca
n 
D
iff
er
en
ce
 in
M
as
s 
Sc
or
e
0
−200
−400
0 250 500 750 1,000 1,250 1,550
Mean Mass Score
200
A
Fig. 3—Bland-Altman plots show absolute interscan difference plotted against means of three calcium measures with 95% repeatability limits adjusted for coronary 
artery calcification.
A, Agatston score, r = 0.5985.
B, Calcium volume score, r = 0.5175.
C, Calcium mass score, r = 0.5696.
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points of Agatston score can be presented as a 
relative difference as high as 200% (Agatston 
score scan 1, 0; Agatston score scan 2, 8) or as 
little as 2% (Agatston score scan 1, 400; Ag-
atston score scan 2, 408). In this study, calci-
um volume and calcium mass scores had sig-
nificantly better interscan agreement than did 
Agatston score. This finding is in accordance 
with results of previous studies [33]. Rather 
surprisingly, volume score performs signif-
icantly better than mass score. Results of a 
study by Hoffmann et al. [34] suggested the 
superiority of the mass score. The theoretic 
advantage of mass score over volume score is 
that density information is used to correct for 
partial volume effects. In our ungated scans, 
however, the influence of motion artifacts on 
the density of calcified plaques was far great-
er than the influence of partial volume effects. 
We postulate, therefore, that the positive ef-
fect of the calcium mass score is outdone by 
the relatively poor quality of the scans.
One limitation of our study was that we 
calculated interscan variability between two 
scans at a mean interval of 3 months. To a 
certain extent, this practice interfered with a 
one-to-one comparison with other studies, in 
which two scans usually have been performed 
only minutes apart. Normal progression of 
CAC is estimated at 14–27% per year [15]. 
Consequently, part of the variability observed 
in our study may be attributed to the real pro-
gression of CAC over the course of 3 months. 
Therefore, we expect that the results of this 
study would have been even better if we had 
performed two baseline scans for all partic-
ipants. Another limitation of our study was 
that in establishing the 95% confidence lim-
its for the three calcium measures, we might 
have controlled for participant-specific covari-
ates (body mass index, CAC score) to improve 
generalization of these results. However, we 
could not adjust calcium scores for body mass 
index. Previous work has shown that greater 
body mass index is associated with lower in-
terscan reproducibility, possibly caused by an 
increase in image noise [35]. The use of a low-
dose scan protocol for overweight participants 
with low CAC scores is likely to interfere with 
accurate detection of true calcification. Even 
when it would have been possible to control 
for all participant-specific covariates, how-
ever, use of different scanner types from dif-
ferent vendors seems to limit even more pro-
foundly the generalization of 95% confidence 
limits derived from a single study [24].
We conclude that CAC scoring with low-
dose ungated MDCT as part of lung cancer 
screening is reliable and has good interscan 
agreement for stratification of participants 
into CVD risk categories. This capability 
makes low-dose ungated MDCT a potential-
ly valuable tool in the assessment of cardio-
vascular risk in large screening populations 
at a substantially reduced radiation dose.
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Mark your calendar for the following ARRS annual meetings:
May 1–6, 2011—Hyatt Regency Chicago, Chicago, IL
April 29–May 4, 2012—Vancouver Convention Center, Vancouver, BC, Canada
April 14–April 19, 2013—Marriott Wardman Park Hotel, Washington, DC
